Continued Efficacy and Safety of Apomorphine in Patients With Late-Stage Parkinsons Disease

NCT00200525 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: apomorphine HCl injection

Sponsor

Mylan Bertek Pharmaceuticals